A multicenter, prospective, randomized, open-label, blinded endpoint trial of intravenous thrombolysis with tenecteplase for acute non-large vessel occlusion in extended time window (OPTION): Rationale and design
一项多中心、前瞻性、随机、开放标签、盲法终点试验，旨在评估替奈普酶静脉溶栓治疗急性非大血管闭塞在延长治疗时间窗内的疗效（OPTION）：研究原理和设计
期刊:Journal of Translational Internal Medicine
影响因子:7.4
doi:10.1515/jtim-2025-0048
Ma, Gaoting; Mo, Ran; Zuo, Yingting; Meng, Shujuan; Wu, Yifan; Jiang, Ziying; Wu, Jieying; Lei, Shaoyuan; Nguyen, Thanh N; Saver, Jeffery L; Wang, Duolao; Zhong, Lianmei; Ma, Qingfeng; Hao, Junwei
